Gut Microbiota and its Metabolites in Pathogenesis of NAFLD

Gut Microbiota and its Metabolites in Pathogenesis of NAFLD

Aim: to provide information on the results of recent scientific research in the field of non-alcoholic fatty liver disease (NAFLD) metabolomic profiling.Key points. Metabolites of microbial origin are important biological molecules involved in many specific reactions of the human body. This literatu...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. S. Reshetova, O. Yu. Zolnikova, V. T. Ivashkin, K. V. Ivashkin, S. A. Appolonova, T. L. Lapina
Format:	Article
Language:	Russian
Published:	Gastro LLC 2023-02-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	metabolites metabolomic profiling biomarkers mass spectrometry liquid chromatography non-alcoholic fatty liver disease
Online Access:	https://www.gastro-j.ru/jour/article/view/711
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Metabolomic profiles as a new understanding of disease processes
by: O. Yu. Zolnikova, et al.
Published: (2022-05-01)

Study on the potential diagnostic value of metabolomics changes in different biological fluids for aspiration pneumonia
by: Lianghui Chen, et al.
Published: (2025-02-01)

Fecal microbiota transplantation alleviates radiation enteritis by modulating gut microbiota and metabolite profiles
by: Qin Ding, et al.
Published: (2025-02-01)

Storage stability study of metronidazole and hydroxymetronidazole in chicken eggs by liquid chromatography tandem mass spectrometry
by: Mikhail Vokuev, et al.
Published: (2025-01-01)

Finding the best column for polar basic analytes across reversed-phase and hydrophilic interaction liquid chromatography
by: József Simon, et al.
Published: (2025-02-01)

Analysis of differential metabolites in Liuyang douchi at different fermentation stages based on untargeted metabolomics approach
by: Liwen Jiang, et al.
Published: (2025-01-01)

Direct and Indirect Methods for Studying Human Gut Microbiota
by: V. T. Ivashkin, et al.
Published: (2022-08-01)

Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis
by: Fufangyu Zhao, et al.
Published: (2025-02-01)

Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01)

Metabolomic profile and its association with the diagnosis of prostate cancer: a systematic review
by: Angela Patricia Salinas Pita, et al.
Published: (2024-12-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Role of gut microbiota and fecal metabolites in the protective effect of soybean pulp-rich diet against estrogen-induced cholestasis in rats
by: Jiawei Wang, et al.
Published: (2025-01-01)

Metabolite profile and antioxidant activities of Trikatu, black pepper, Javanese long pepper, and red ginger essential oils
by: Dewa Ayu Ika Pramitha, et al.
Published: (2025-02-01)

Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment
by: Ye. N. Shirokova
Published: (2023-08-01)

Unraveling the levels of emerging contaminants along the eastern Mediterranean Sea
by: Fatima Haydous, et al.
Published: (2025-02-01)

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
by: R. V. Maslennikov, et al.
Published: (2018-09-01)

Differences in Metabolites of Different Varieties from Xinjiang Large-fruit Sea Buckthorn as Analyzed by Non-targeted Metabolomics
by: Rong HAN, et al.
Published: (2025-02-01)

Epidemiologic features of non-alcoholic fatty liver disease in Russia
by: O. M. Drapkina, et al.
Published: (2014-10-01)

Xiaohua Funing decoction ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and bile acids
by: Jindong Zhao, et al.
Published: (2025-02-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Effects of highland barley β-glucan on gut microbiota composition and metabolism in vitro fermentation
by: Yinchen Ge, et al.
Published: (2025-01-01)

Lipotoxicity and metabolic disorders at obesity
by: V. T. Ivashkin, et al.
Published: (2010-02-01)

Effects of Different Aging Treatments on Functional Components and Flavor Substances of Chrysanthemum Rice Wine
by: Wei GAO, et al.
Published: (2025-02-01)

Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program)
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease
by: O. Yu. Kytikova, et al.
Published: (2020-05-01)

The Role of Gut Microbiota in Hypertension Management - A Review
by: Alicja Kot, et al.
Published: (2025-02-01)

Simultaneous determination of 11 kinds of siloxanes in drinking water and source water using solid-phase microextraction combined with gas chromatography-mass spectrometry
by: Sijie Liu, et al.
Published: (2025-02-01)

Characterization and comparative analysis of volatile organic compounds in four aromatic wild strawberry species using HS-SPME-GC-MS
by: Linlin Xu, et al.
Published: (2025-01-01)

Phytochemical components and antibacterial activity of two populations of Senecio vulgaris L. essential oils as traditional medicine plant
by: Fatemeh Hajmoradi, et al.
Published: (2025-02-01)

Effects of the Treatment Technology of Soybean on Volatile Flavor Compounds of Plant-based Compound Milk during Storage
by: Xue WANG, et al.
Published: (2025-02-01)

Cassava–soybean intercropping alleviates continuous cassava cropping obstacles by improving its rhizosphere microecology
by: Huixian Chen, et al.
Published: (2025-02-01)

Phenotypes of Non-Alcoholic Fatty Liver Disease in Different Regions of the Russian Federation, Diagnostic and Therapeutic Approach in Clinical Practice
by: V. T. Ivashkin, et al.
Published: (2023-08-01)

Risk of Cirrhosis in Patients with Non-alcoholic Fatty Liver Disease and Previous Viral Hepatitis B
by: S. N. Batskikh, et al.
Published: (2020-09-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Modulating the developing gut microbiota with 2’-fucosyllactose and pooled human milk oligosaccharides
by: Simone Renwick, et al.
Published: (2025-02-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Comparative Efficacy of NAFLD Therapies and Biomarker Associations: A Meta-Analysis Based on Liver Fat Content
by: Haoxiang Zhu, et al.
Published: (2025-01-01)

An Effect of Ursodeoxycholic Acid on Inflammation, Steatosis and Liver Fibrosis and Atherogenesis Factors in Patients with Non-Alcoholic Fatty Liver Disease: Results of the USPEH Study
by: M. V. Mayevskaya, et al.
Published: (2020-01-01)

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: A. E. Bagriy, et al.
Published: (2021-06-01)

Exploring the microbiota-gut-brain axis: impact on brain structure and function
by: Lidya K. Yassin, et al.
Published: (2025-02-01)